Roche re­gains pre-pan­dem­ic sales foot­ing, high­lights burst­ing pipeline — with one key fail­ure

While many phar­ma for­tunes are tied to Covid-19 pan­dem­ic peaks and val­leys, Roche’s con­nec­tions are more com­pli­cat­ed than most, born out in its 2021 fi­nan­cial …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER